AKANVSOBIO• 6 Months (Normalized)
AKAN vs OBIO (Akanda Corp. vs Orchestra BioMed Holdings Inc.)
Showing Closing Date Range from Mar, 19 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AKAN Performance $2.72
-24.99%
Akanda Corp.
Normalized Baseline0.00%
OBIO Performance $6.01
+29.53%
Orchestra BioMed Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin OBIO LEADS
-54.52%
OBIO outperforming by 54.52%
AKANOBIO
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AKAN OBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | AKAN Price | AKAN Gain (%) | OBIO Price | OBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.72 | -24.99% | $6.01 | +29.53% | -54.52% |
| Sep 14, 2026 | $2.79 | -23.06% | $5.90 | +27.16% | -50.22% |
| Sep 11, 2026 | $3.07 | -15.34% | $6.12 | +31.90% | -47.24% |
| Sep 10, 2026 | $3.00 | -17.27% | $5.81 | +25.22% | -42.49% |
| Sep 09, 2026 | $3.25 | -10.37% | $5.45 | +17.46% | -27.83% |
| Sep 08, 2026 | $3.28 | -9.54% | $5.43 | +17.03% | -26.57% |
| Sep 04, 2026 | $3.35 | -7.61% | $5.08 | +9.48% | -17.09% |
| Sep 03, 2026 | $3.67 | +1.21% | $4.74 | +2.16% | -0.95% |
| Sep 02, 2026 | $3.74 | +3.14% | $4.95 | +6.68% | -3.54% |
| Sep 01, 2026 | $3.70 | +2.04% | $4.90 | +5.60% | -3.56% |
| Aug 31, 2026 | $4.08 | +12.38% | $5.04 | +8.62% | +3.76% |
| Aug 28, 2026 | $3.89 | +7.28% | $5.19 | +11.75% | -4.47% |
| Aug 27, 2026 | $4.23 | +16.65% | $5.11 | +10.13% | +6.52% |
| Aug 26, 2026 | $4.24 | +16.93% | $5.26 | +13.36% | +3.57% |
| Aug 25, 2026 | $4.95 | +36.51% | $5.36 | +15.52% | +20.99% |
Page 1 of 9